https://www.taxtmi.com/news?id=72233 India's pharmaceutical exports continued to grow, with exports up to February exceeding USD 28 billion and rising 5.6 per cent year-on-year, led by formulations, biologicals, vaccines and AYUSH products. Industry representatives said the sector is likely to end the financial year broadly in line with the previous year, despite global pricing pressure and trade volatility, while future growth is expected through policy prioritisation, market diversification, foreign direct investment and improved regulatory efficiency. en-us Sat, 04 Apr 2026 18:31:03 +0530 Sat, 04 Apr 2026 18:31:03 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=72233 India's pharmaceutical exports continued to grow, with exports up to February exceeding USD 28 billion and rising 5.6 per cent year-on-year, led by formulations, biologicals, vaccines and AYUSH products. Industry representatives said the sector is likely to end the financial year broadly in line with the previous year, despite global pricing pressure and trade volatility, while future growth is expected through policy prioritisation, market diversification, foreign direct investment and improved regulatory efficiency. News - Sat, 04 Apr 2026 18:31:03 +0530 https://www.taxtmi.com/news?id=72233